SI-BONE (SIBN) news
Recent news
Si-Bone Q2 EPS USD -0.09
SI-BONE, Inc. (Nasdaq: SIBN) reported second-quarter 2026 earnings per share (EPS) of -$0.09, according to its most recent financial results. This represents an improvement from the prior quarter’s loss of $0.14 per share and the year-ago loss of $0.22 . The company also exceeded revenue…
AInvest Wire · Aug 3, 2026SI-BONE (SIBN) receives FDA nod for its TNT implant system
SI-BONE (SIBN) receives FDA nod for its TNT implant system The US Food and Drug Administration (FDA) has granted 510(k) clearance and Breakthrough Device Designation (BDD) to SI-BONE, Inc. (Nasdaq: SIBN) for its iFuse TORQ TNT™ Implant System (TNT) [1]. This groundbreaking technology, designed…
AInvest Wire · Sep 13, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.